Theriva Biologics TOVX
NYSE TOVX
$0.20 -0.01 (-3.80%)
As of: Oct 21, 2026 · 3:35 PM EDT

Theriva Biologics (TOVX) EBITDA Margin (2010 - 2026)

Updated

Theriva Biologics (TOVX) recorded EBITDA Margin of -701.00% in Q1 2026.

Analysis

Theriva Biologics (TOVX) EBITDA Margin (2010 - 2026) Analysis & Trends

For FY2010, Theriva Biologics reported EBITDA Margin of -28.19%.

  • The Q1 2026 figure is the highest quarterly EBITDA Margin since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn 35.95%
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn 49.01%
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn -
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn 33.11%
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn -124.26%
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 39.16%
10 Theriva Biologics 9.18 Mn -37.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -701.00%
Sep 30, 2011 -308.85%
Jun 30, 2011 -252.70%
Sep 30, 2010 -221.50%
API Access

Theriva Biologics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TOVX&period=max&api_key=YOUR_API_KEY